Clinicopathological characteristics of primary breast cancer in older geriatric women: A study of 39 Japanese patients over 80 years old

Japanese Journal of Cancer Research

Volumn 88, Issue 7, 1997, Pages 693-699

  Morishita, Yukio ^a   Tsuda, Hitoshi ^a   Fukutomi, Takashi ^b   Mukai, Kiyoshi ^a   Shimosato, Yukio ^b   Hirohashi, Setsuo ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

Breast cancer; C erbB 2; Elderly women; Histological grade; Lymph node metastasis

Indexed keywords

AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER MORTALITY; CANCER SURVIVAL; CLINICAL ARTICLE; HISTOLOGY; HUMAN; JAPAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MASTECTOMY; ONCOGENE C ERB; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0030763290     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1997.tb00438.x     Document Type: Article

References (17)

1. Muir, C., Waterhouse, J. and Mack, T. "Cancer Incidence in Five Continents, Vol. 5," pp. 574-580 (1987). IARC Scientific Publications, Lyon.
2. "Figures on Cancer in Japan" Publishing Committee. "Figures on Cancer in Japan - 1993," p. 14 (1993). Foundation for Promotion of Cancer Research, Tokyo.
3. Bloom, H. J. G. and Richardson, W. W. Histological grading and prognosis in breast cancer. Br. J. Cancer, 11, 359-377 (1957).
4. Page, D. L., Anderson, T. J. and Sakamoto, G. Infiltrating carcinoma: major histological types. In "Diagnostic Histopathology of the Breast," ed. D. L. Page and T. J. Anderson, pp. 193-235 (1992). Livingstone Churchill, New York.
5. Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A. and McGuire, W. L. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science, 235, 177-182 (1987).
6. Wright, C., Angus, B., Nicholson, S., Sainsbury, J. R. C., Cairns, J., Gullick, W. J., Kelly, P., Harris, A. L. and Home, C. H. W. Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer. Cancer Res., 49, 2087-2090 (1989).
7. Tsuda, H., Hirohashi, S., Shimosato, Y., Hirota, T., Tsugane, S., Watanabe, S., Terada, M. and Yamamoto, H. Correlation between histologic grade of malignancy and copy number of c-erbB-2 gene in breast carcinoma. Cancer, 65, 1794-1800 (1990).
8. Tsuda, H., Hirohashi, S., Shimosato, Y., Tanaka, Y., Hirota, T., Tsugane, S., Shiraishi, M., Toyoshima, K., Yamamoto, T., Terada, M. and Sugimura, T. Immunohistochemical study on overexpression of c-erbB-2 protein in human breast cancer: its correlation with gene amplification and long-term survival of patients. Jpn. J. Cancer Res., 81, 327-332 (1990).
9. Yancik, R., Ries, L. G. and Yates, J. W. Breast cancer in aging women: a population-based study of contrasts in stage, surgery, and survival. Cancer, 63, 976-981 (1989).
10. Swanson, R. S., Sawicka, J. and Wood, W. C. Treatment of carcinoma of the breast in the older geriatric patient. Surg. Gynecol. Obstet., 173, 465-469 (1991).
11. Singletary, S. E., Shallenberger, R. and Guinee, V. F. Breast cancer in the elderly. Ann. Surg., 218, 667-671 (1993).
12. Kaplan, E. L. and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53, 457-481 (1958).
13. Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J. and Smith, P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient: II. analysis and examples. Br. J. Cancer, 35, 1-39 (1977).
14. Peer, P. G. M., van Dijck, J. A. A. M., Hendriks, J. H. C. L., Holland, R. and Verbeek, A. L. M. Age-dependent growth rate of primary breast cancer. Cancer, 71, 3547-3551 (1993).
15. Stewart, J. A. and Foster, R. S., Jr. Breast cancer and aging. Semin. Oncol., 16, 41-50 (1989).
16. Veronesi, U., Luini, A., Vecchio, M. D., Greco, M., Galimberti, V., Merson, M., Rilke, F., Sacchini, V., Saccozzi, R., Savio, T., Zucali, R., Zurrida, S. and Salvadori, B. Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. N. Engl. J. Med., 328, 1587-1591 (1993).
17. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31000 recurrences and 24000 deaths among 75000 women. Lancet, 339, 1-15, 71-85 (1992).